Abstract
Evaluation of the adaptive immune response is critical to the advancement of our basic knowledge and understanding of respiratory syncytial virus (RSV). The cellular composition in the lung following RSV infection is often evaluated using flow cytometry. However, a limitation of this approach has been the inability to readily distinguish cells that are within the lung parenchyma from cells that remain in the pulmonary blood vessels. Herein, we detail a procedure to evaluate the adaptive immune response via flow cytometric analysis that incorporates an in vivo intravascular staining technique. This technique allows for discrimination of immune cells in the lung tissue from cells that remain in the pulmonary vasculature following perfusion. Therefore at any given time point following an RSV infection, the leukocytic populations in the lung parenchyma can be quantified and phenotypically assessed with high resolution. While we focus on the T lymphocyte response in the lung, this technique can be readily adapted to examine various leukocytic cell types in the lung following RSV infection.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hall CB, Walsh EE, Long CE, Schnabel KC (1991) Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 163(4):693–698
Glezen WP, Taber LH, Frank AL, Kasel JA (1986) Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140(6):543–546
Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL (1981) Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 98(5):708–715
Groothuis JR, Simoes EA, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC et al (1993) Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med 329(21):1524–1530. doi:10.1056/NEJM199311183292102
McIntosh K, Masters HB, Orr I, Chao RK, Barkin RM (1978) The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis 138(1):24–32
Graham BS, Bunton LA, Rowland J, Wright PF, Karzon DT (1991) Respiratory syncytial virus infection in anti-mu-treated mice. J Virol 65(9):4936–4942
Graham BS, Bunton LA, Wright PF, Karzon DT (1991) Reinfection of mice with respiratory syncytial virus. J Med Virol 34(1):7–13
Graham BS, Bunton LA, Wright PF, Karzon DT (1991) Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 88(3):1026–1033. doi:10.1172/JCI115362
Bangham CR, Openshaw PJ, Ball LA, King AM, Wertz GW, Askonas BA (1986) Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J Immunol 137(12):3973–3977
Anderson KG, Sung H, Skon CN, Lefrancois L, Deisinger A, Vezys V, Masopust D (2012) Cutting edge: intravascular staining redefines lung CD8 T cell responses. J Immunol 189(6):2702–2706. doi:10.4049/jimmunol.1201682
Knudson CJ, Weiss KA, Hartwig SM, Varga SM (2014) The pulmonary localization of virus-specific T lymphocytes is governed by the tissue tropism of infection. J Virol 88(16):9010–9016. doi:10.1128/JVI.00329-14
Teijaro JR, Turner D, Pham Q, Wherry EJ, Lefrancois L, Farber DL (2011) Cutting edge: Tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J Immunol 187(11):5510–5514. doi:10.4049/jimmunol.1102243
Galkina E, Thatte J, Dabak V, Williams MB, Ley K, Braciale TJ (2005) Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. J Clin Invest 115(12):3473–3483. doi:10.1172/JCI24482
Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ (2002) Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 76(11):5654–5666
Tyrrell DA, Mika-Johnson M, Phillips G, Douglas WH, Chapple PJ (1979) Infection of cultured human type II pneumonocytes with certain respiratory viruses. Infect Immun 26(2):621–629
McDermott DS, Knudson CJ, Varga SM (2014) Determining the breadth of the respiratory syncytial virus-specific T cell response. J Virol 88(6):3135–3143. doi:10.1128/JVI.02139-13
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Knudson, C.J., Weiss, K.A., Stoley, M.E., Varga, S.M. (2016). Evaluation of the Adaptive Immune Response to Respiratory Syncytial Virus. In: Tripp, R., Jorquera, P. (eds) Human Respiratory Syncytial Virus. Methods in Molecular Biology, vol 1442. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3687-8_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3687-8_17
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3685-4
Online ISBN: 978-1-4939-3687-8
eBook Packages: Springer Protocols